Matthew Shaulis

Matthew Shaulis has extensive work experience in the pharmaceutical and biotech industry. Matthew is currently serving as the Chief Commercial Officer & US President at Hansa Biopharma since March 2023. Prior to this, they held various roles at Pfizer, including SVP Global Commercial & Medical Transformation from April 2021 to March 2023, President, International Developed Markets, Inflammation & Immunology from December 2018 to June 2021, and President, North America at Pfizer Oncology from January 2016 to December 2018. Matthew also served as the VP US Oncology Commercial at Pfizer Oncology from July 2015 to January 2016. Before joining Pfizer, they had roles at Teva as VP Global CNS, MS in 2015 and at Teva Oncology as Head of Oncology Sales & Strategic Customer Group from 2010 to 2015. Prior to that, they worked at Cephalon as the Head of Oncology Marketing from 2007 to 2010 and at Ortho Biotech as a Product Director from 2003 to 2007.

Matthew Shaulis attended Penn State University and obtained a Bachelor of Science (BS) degree. Matthew then pursued their education at Duke University - The Fuqua School of Business, where they completed a Master of Business Administration (MBA) degree. No specific field of study is mentioned for either degree.